T1	Participants 207 256	adults with smear-positive pulmonary tuberculosis
T2	Participants 308 459	trials enrolled human immunodeficiency virus (HIV) infected participants who were not receiving antiretroviral therapy (ART) at TB treatment initiation
#1	AnnotatorNotes T2	patients have both HIV and TB
T3	Participants 698 793	750 participants who received at least one dose of study treatment, 123 (16%) were HIV-infected
